Search Tag: Radiopharmaceuticals

Executive Health Management

2022 07 Nov

Fusion Pharmaceuticals Inc, a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines announced the appointment of Dmitri Bobilev, M.D., as chief medical officer. "We are pleased to welcome Dmitri to Fusion's leadership team at a time when Fusion has three Phase 1 novel targeted alpha therapy...Read more